{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:44:49Z","timestamp":1781783089566,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejca.2021.09.031","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:39:01Z","timestamp":1635899941000},"page":"60-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Impact of 18F-Fluorodeoxyglucose positron emission tomography on management of cancer of unknown primary: systematic review and meta-analysis"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-8369","authenticated-orcid":false,"given":"Sungmin","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-6496","authenticated-orcid":false,"given":"Anton S.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-0310","authenticated-orcid":false,"given":"Richard K.G.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2240-9694","authenticated-orcid":false,"given":"Hedvig","family":"Hricak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Alberto Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9824","key":"10.1016\/j.ejca.2021.09.031_bib1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","article-title":"Cancer of unknown primary site","volume":"379","author":"Pavlidis","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2021.09.031_bib2","series-title":"NCCN clinical practice guidelines in oncology occult primary","year":"2019"},{"issue":"17","key":"10.1016\/j.ejca.2021.09.031_bib3","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2000.18.17.3101","article-title":"Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study","volume":"18","author":"Briasoulis","year":"2000","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2021.09.031_bib4","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1158\/1078-0432.CCR-04-2236","article-title":"Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm","volume":"11","author":"Dennis","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ejca.2021.09.031_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamaoncol.2019.3985","article-title":"Development of genome-derived tumour type prediction to inform clinical cancer care","volume":"6","author":"Penson","year":"2019","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2021.09.031_bib6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ejrad.2016.08.020","article-title":"Hybrid imaging for detection of carcinoma of unknown primary: a preliminary comparison trial of whole-body PET\/MRI versus PET\/CT","volume":"85","author":"Ruhlmann","year":"2016","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1016\/j.ejca.2021.09.031_bib7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMra1303917","article-title":"Cancer of unknown primary site","volume":"371","author":"Varadhachary","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2021.09.031_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.suronc.2013.06.002","article-title":"18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis","volume":"22","author":"Zhu","year":"2013","journal-title":"Surg Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2021.09.031_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006713","article-title":"18F-FDG PET\/CT for detection of the primary tumour in adults with extracervical metastases from cancer of unknown primary: a systematic review and meta-analysis","volume":"96","author":"Burglin","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ejca.2021.09.031_bib10","first-page":"15","article-title":"Role of whole body positron emission tomography\/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumour metastases from unknown primary site","volume":"50","author":"Pelosi","year":"2006","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.ejca.2021.09.031_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting Items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"J Am Med Assoc"},{"issue":"10","key":"10.1016\/j.ejca.2021.09.031_bib12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.ejca.2021.09.031_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"Group Q-. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2021.09.031_bib14","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2011"},{"issue":"9","key":"10.1016\/j.ejca.2021.09.031_bib15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.ejca.2021.09.031_bib16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/00006231-200310000-00008","article-title":"Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome)","volume":"24","author":"Alberini","year":"2003","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.ejca.2021.09.031_bib17","first-page":"5","article-title":"Diagnostic performance of F-18 FDG PET\/CT in patients with cancer of unknown primary: additional benefit over CT-based conventional work up","volume":"4","author":"Bakhshayeshkaram","year":"2016","journal-title":"Novel Biomed"},{"issue":"5","key":"10.1016\/j.ejca.2021.09.031_bib18","first-page":"242","article-title":"On the interest of PET with 18 F-FDG in the management of cancer of unknown primary (CUP)","volume":"31","author":"Bruna","year":"2007","journal-title":"Med Nucl"},{"issue":"2","key":"10.1016\/j.ejca.2021.09.031_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/0019-509X.82882","article-title":"Utility of PET in unknown primary with cervical metastasis: a retrospective study","volume":"48","author":"Dandekar","year":"2011","journal-title":"Indian J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2021.09.031_bib20","first-page":"331","article-title":"Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: impact of (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"26","author":"Deron","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ejca.2021.09.031_bib21","first-page":"S590","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography in carcinoma of unknown primary: 6-year single institution experience","volume":"39","author":"Elboga","year":"2012","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ejca.2021.09.031_bib22","first-page":"S558","article-title":"Unknown primary tumours in patients with verified cervical lymph node metastases: the clinical impact of FDG PET-CT","volume":"39","author":"Fulop","year":"2012","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"10.1016\/j.ejca.2021.09.031_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07357900701206331","article-title":"Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primary","volume":"25","author":"Garin","year":"2007","journal-title":"Cancer Invest"},{"issue":"11","key":"10.1016\/j.ejca.2021.09.031_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/01.mnm.0000184940.06123.f0","article-title":"Early clinical experience and impact of 18F-FDG PET","volume":"26","author":"Gutte","year":"2005","journal-title":"Nucl Med Commun"},{"issue":"7","key":"10.1016\/j.ejca.2021.09.031_bib25","first-page":"1010","article-title":"Clinical applications of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in carcinoma of unknown primary","volume":"124","author":"Hu","year":"2011","journal-title":"Chin Med J"},{"issue":"924","key":"10.1016\/j.ejca.2021.09.031_bib26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1259\/bjr\/69059431","article-title":"In search of an unknown primary tumour presenting with extracervical metastases: the diagnostic performance of FDG-PET","volume":"77","author":"Joshi","year":"2004","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.ejca.2021.09.031_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1067\/mhn.2000.104807","article-title":"2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation","volume":"123","author":"Jungeh\u00fclsing","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.ejca.2021.09.031_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4274\/Mirt.344","article-title":"Impact of FDG-PET\/CT for the detection of unknown primary tumours in patients with cervical lymph node metastases","volume":"21","author":"Karapolat","year":"2012","journal-title":"Mol Imag Radionucl Ther"},{"issue":"12","key":"10.1016\/j.ejca.2021.09.031_bib29","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00006231-200512000-00003","article-title":"FDG PET in patients with cancer of an unknown primary","volume":"26","author":"Kolesnikov-Gauthier","year":"2005","journal-title":"Nucl Med Commun"},{"issue":"7","key":"10.1016\/j.ejca.2021.09.031_bib30","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0959-8049(99)00077-5","article-title":"18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)","volume":"35","author":"Lassen","year":"1999","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2021.09.031_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1095-0397(00)00053-4","article-title":"Metastases from unknown primary tumour. PET-FDG as initial diagnostic procedure?","volume":"3","author":"Lonneux","year":"2000","journal-title":"Clin Positron Imaging"},{"issue":"1","key":"10.1016\/j.ejca.2021.09.031_bib32","first-page":"47","article-title":"PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients' diagnostic and therapeutic management","volume":"18","author":"Mantaka","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"10.1016\/j.ejca.2021.09.031_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00405-008-0733-6","article-title":"18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma","volume":"266","author":"Padovani","year":"2009","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.ejca.2021.09.031_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1756-0500-4-56","article-title":"Detection of primary sites in unknown primary tumours using FDG-PET or FDG-PET\/CT","volume":"4","author":"Park","year":"2011","journal-title":"BMC Res Notes"},{"issue":"11","key":"10.1016\/j.ejca.2021.09.031_bib35","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1023\/A:1013107732572","article-title":"Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management","volume":"12","author":"Rades","year":"2001","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2021.09.031_bib36","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00259-002-0819-0","article-title":"Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities","volume":"29","author":"Regelink","year":"2002","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"3","key":"10.1016\/j.ejca.2021.09.031_bib37","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00330-019-06518-9","article-title":"Impact of PET\/CT on clinical management in patients with cancer of unknown primary-a PET\/CT registry study","volume":"30","author":"Reinert","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejca.2021.09.031_bib38","first-page":"S721","article-title":"(18) F-FDG PET-TC imaging in the detection of primary tumours in patients with metastatic carcinoma of unknown primary origin: a multicentric study","volume":"42","author":"Rossi","year":"2015","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"3","key":"10.1016\/j.ejca.2021.09.031_bib39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s13193-013-0225-z","article-title":"The role of 18 FDG PET-CT in evaluation of unknown primary tumours","volume":"4","author":"Saidha","year":"2013","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.ejca.2021.09.031_bib40","article-title":"Impact of 18F FDG PET CT on initial management of patients presenting with secondaries in neck from an unknown primary","volume":"42","author":"Sarma","year":"2015","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"3","key":"10.1016\/j.ejca.2021.09.031_bib41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11307-005-4114-x","article-title":"The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin","volume":"7","author":"Scott","year":"2005","journal-title":"Mol Imag Biol"},{"issue":"4","key":"10.1016\/j.ejca.2021.09.031_bib42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1368-8375(98)00129-8","article-title":"The detection of unknown primary tumours in patients with cervical metastases by dual-head positron emission tomography","volume":"35","author":"Stokkel","year":"1999","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2021.09.031_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.kjms.2016.07.004","article-title":"Defining risk groups of patients with cancer of unknown primary site and cervical nodal metastases by F-18 fluorodeoxyglucose positron emission tomography and computed tomography imaging","volume":"32","author":"Su","year":"2016","journal-title":"Kaohsiung J Med Sci"},{"issue":"9","key":"10.1016\/j.ejca.2021.09.031_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1634\/theoncologist.2015-0364","article-title":"Impact on patient management of [18F]-Fluorodeoxyglucose-Positron emission tomography (PET) used for cancer diagnosis: analysis of data from the national oncologic PET registry","volume":"21","author":"Subramaniam","year":"2016","journal-title":"Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2021.09.031_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21608\/egyjnm.2019.106659","article-title":"Impact of 18 F-FDG-PET\/CT in detection of the primary site and change management in patients with metastases of unknown primary","volume":"19","author":"Talaat","year":"2019","journal-title":"Egypt J Nucl Med"},{"issue":"4","key":"10.1016\/j.ejca.2021.09.031_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1095-0397(00)00072-8","article-title":"6. 18F-FDG whole body positron emission tomography (PET) in the detection of unknown primary tumours","volume":"3","author":"Trampal","year":"2000","journal-title":"Clin Positron Imaging"},{"issue":"1","key":"10.1016\/j.ejca.2021.09.031_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1754-9485.2012.02441.x","article-title":"Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography\/computed tomography in patients with carcinoma of unknown primary","volume":"57","author":"Wang","year":"2013","journal-title":"J Med Imag Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2021.09.031_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MNM.0b013e3280708edf","article-title":"In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT","volume":"28","author":"Wartski","year":"2007","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.ejca.2021.09.031_bib49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4103\/0971-3026.190412","article-title":"Efficacy of 18F-FDG PET\/CT in investigation of elevated CEA without known primary malignancy","volume":"26","author":"Wong","year":"2016","journal-title":"Indian J Radiol Imag"},{"issue":"32","key":"10.1016\/j.ejca.2021.09.031_bib50","first-page":"2253","article-title":"The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography in the management of unknown primary tumours","volume":"87","author":"Wu","year":"2007","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"5","key":"10.1016\/j.ejca.2021.09.031_bib51","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.3892\/ol.2016.5203","article-title":"Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography\/computed tomography in carcinoma of unknown primary","volume":"12","author":"Yu","year":"2016","journal-title":"Oncol Lett"},{"issue":"10","key":"10.1016\/j.ejca.2021.09.031_bib52","first-page":"685","article-title":"1\u2078F-fluorodeoxyglucose positron emission tomography\/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumour","volume":"27","author":"Zhao","year":"2012","journal-title":"Cancer Biother Radiopharm"},{"issue":"7","key":"10.1016\/j.ejca.2021.09.031_bib53","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.18.00771","article-title":"Randomized phase II trial comparing site-specific treatment based on gene expression profiling with carboplatin and paclitaxel for patients with cancer of unknown primary site","volume":"37","author":"Hayashi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2021.09.031_bib54","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12020-019-01934-9","article-title":"Detection rate of unknown primary tumour by using somatostatin receptor PET\/CT in patients with metastatic neuroendocrine tumours: a meta-analysis","volume":"64","author":"De Dosso","year":"2019","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ejca.2021.09.031_bib55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.ejca.2021.09.031_bib56","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s00259-020-05055-8","article-title":"Improved cancer detection in Waldeyer's tonsillar ring by (68)Ga-FAPI PET\/CT imaging","volume":"48","author":"Serfling","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492101131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492101131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:33:26Z","timestamp":1760733206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492101131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":56,"alternative-id":["S095980492101131X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.09.031","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of 18F-Fluorodeoxyglucose positron emission tomography on management of cancer of unknown primary: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}